PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.23%
Positive revenue growth while MRVL is negative. John Neff might see a notable competitive edge here.
5.71%
Gross profit growth at 75-90% of MRVL's 7.27%. Bill Ackman would demand operational improvements to match competitor gains.
0.51%
EBIT growth below 50% of MRVL's 16.16%. Michael Burry would suspect deeper competitive or cost structure issues.
6.95%
Operating income growth under 50% of MRVL's 16.16%. Michael Burry would be concerned about deeper cost or sales issues.
3.85%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
3.83%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
3.89%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.33%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.32%
Slight or no buyback while MRVL is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.01%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-12.94%
Negative OCF growth while MRVL is at 214.53%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-19.39%
Negative FCF growth while MRVL is at 300.87%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
60.04%
Positive 10Y revenue/share CAGR while MRVL is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
55.67%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
20.69%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
353.80%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
269.23%
5Y OCF/share CAGR above 1.5x MRVL's 132.10%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
77.37%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
233.16%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
169.17%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
36.82%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
21.69%
Below 50% of MRVL's 75.43%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
13.46%
Below 50% of MRVL's 29.41%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
1.85%
Below 50% of MRVL's 63.57%. Michael Burry suspects a serious short-term disadvantage in building book value.
677.64%
Dividend/share CAGR of 677.64% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
167.94%
5Y dividend/share CAGR above 1.5x MRVL's 0.08%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
64.02%
3Y dividend/share CAGR above 1.5x MRVL's 0.66%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
12.02%
Our AR growth while MRVL is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-3.32%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.49%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
10.30%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
-12.21%
We’re deleveraging while MRVL stands at 0.06%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.52%
Our R&D shrinks while MRVL invests at 0.07%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
6.78%
SG&A growth well above MRVL's 0.36%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.